Medical Properties Trust (MPT) Q2 2024 earnings summary

Executive summary

• Generated over $2.5 billion in liquidity year-to-date, exceeding initial targets and enabling expedited debt paydown.

• Portfolio remains diversified and resilient, with strong performance in key segments and a strategic focus on value realization.

• Steward Health Care's Chapter 11 restructuring is ongoing, introducing uncertainty and significant impairment charges.

• Major asset sales and joint ventures, including $1.1 billion from Utah hospitals and $350 million from Prime Healthcare, generated over $1.3 billion in proceeds.

• Revenues declined 21% year-over-year to $266.6 million, mainly due to lower rent and asset disposals.

Financial highlights

• Reported GAAP net loss of $320.6 million ($0.54 per share) for Q2 2024, driven by $960 million in Steward-related impairments and fair value adjustments.

• Normalized FFO was $139.4 million ($0.23 per share) for Q2 2024, down 51% year-over-year.

• Q2 included $19 million in consolidated cash revenue from Steward and $22 million from Prospect.

• Cash and cash equivalents at June 30, 2024: $606.6 million.

• Approximately $550 million in non-cash impairment charges, mainly from the Massachusetts partnership.

Outlook and guidance

• Confident in ability to satisfy 2025 and beyond maturities through liquidity levers and asset monetization, but risk remains if further extensions are not approved.

• Expectation to transition or sell virtually all Steward-leased assets by September 2025.

• Dividend capped at $0.08 per share per quarter in cash through Q3 2025, with flexibility for additional payout if required.

• No material real estate acquisitions expected in the near term; focus remains on liquidity and debt reduction.